Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test (Q43775256)
Jump to navigation
Jump to search
scientific article published in October 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test |
scientific article published in October 2001 |
Statements
1 reference
Inhibition of cytochrome P4502D6 activity with paroxetine normalizes the ultrarapid metabolizer phenotype as measured by nortriptyline pharmacokinetics and the debrisoquin test (English)
1 reference
Laine K
1 reference
Tybring G
1 reference
Härtter S
1 reference
Andersson K
1 reference
Svensson JO
1 reference
Widén J
1 reference
Bertilsson L
1 reference
1 October 2001
1 reference
1 reference
70
1 reference
4
1 reference
327-335
1 reference
Identifiers
1 reference
1 reference